Non-Steroidal Anti-Inflammatory Drugs Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Non-Steroidal Anti-Inflammatory Drugs Market, By Indication (Arthritis, Migraine, Ophthalmic Diseases, Others), By Route of Administration(Oral, Parenteral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
Non-Steroidal Anti-Inflammatory Drugs Market Size
Market Size in USD
CAGR5.7%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 5.7% |
| Market Concentration | High |
| Major Players | Pfizer Inc., Johnson & Johnson Services, Inc., Bayer AG, Sanofi, GSK plc |
please let us know !
Non-Steroidal Anti-Inflammatory Drugs Market Analysis
The non-steroidal anti-inflammatory drugs market is estimated to be valued at USD 24.4 Bn in 2024 and is expected to reach USD 36 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031. The market has been observing steady growth over the past few years driven by rising geriatric population and increasing prevalence of arthritis disorders worldwide.